Global Biologics in Spine Surgery Market Research Report 2024(Status and Outlook)
Report Overview:
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
The Global Biologics in Spine Surgery Market Size was estimated at USD 2252.69 million in 2023 and is projected to reach USD 3018.83 million by 2029, exhibiting a CAGR of 5.00% during the forecast period.
This report provides a deep insight into the global Biologics in Spine Surgery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics in Spine Surgery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics in Spine Surgery market in any manner.
Global Biologics in Spine Surgery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Market Segmentation (by Type)
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics in Spine Surgery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
The Global Biologics in Spine Surgery Market Size was estimated at USD 2252.69 million in 2023 and is projected to reach USD 3018.83 million by 2029, exhibiting a CAGR of 5.00% during the forecast period.
This report provides a deep insight into the global Biologics in Spine Surgery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics in Spine Surgery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics in Spine Surgery market in any manner.
Global Biologics in Spine Surgery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Market Segmentation (by Type)
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biologics in Spine Surgery Market
- Overview of the regional outlook of the Biologics in Spine Surgery Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics in Spine Surgery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biologics in Spine Surgery
1.2 Key Market Segments
1.2.1 Biologics in Spine Surgery Segment by Type
1.2.2 Biologics in Spine Surgery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICS IN SPINE SURGERY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biologics in Spine Surgery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biologics in Spine Surgery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICS IN SPINE SURGERY MARKET COMPETITIVE LANDSCAPE
3.1 Global Biologics in Spine Surgery Sales by Manufacturers (2019-2024)
3.2 Global Biologics in Spine Surgery Revenue Market Share by Manufacturers (2019-2024)
3.3 Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics in Spine Surgery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biologics in Spine Surgery Sales Sites, Area Served, Product Type
3.6 Biologics in Spine Surgery Market Competitive Situation and Trends
3.6.1 Biologics in Spine Surgery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics in Spine Surgery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGICS IN SPINE SURGERY INDUSTRY CHAIN ANALYSIS
4.1 Biologics in Spine Surgery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICS IN SPINE SURGERY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOLOGICS IN SPINE SURGERY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics in Spine Surgery Sales Market Share by Type (2019-2024)
6.3 Global Biologics in Spine Surgery Market Size Market Share by Type (2019-2024)
6.4 Global Biologics in Spine Surgery Price by Type (2019-2024)
7 BIOLOGICS IN SPINE SURGERY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics in Spine Surgery Market Sales by Application (2019-2024)
7.3 Global Biologics in Spine Surgery Market Size (M USD) by Application (2019-2024)
7.4 Global Biologics in Spine Surgery Sales Growth Rate by Application (2019-2024)
8 BIOLOGICS IN SPINE SURGERY MARKET SEGMENTATION BY REGION
8.1 Global Biologics in Spine Surgery Sales by Region
8.1.1 Global Biologics in Spine Surgery Sales by Region
8.1.2 Global Biologics in Spine Surgery Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics in Spine Surgery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics in Spine Surgery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics in Spine Surgery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics in Spine Surgery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics in Spine Surgery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Medtronic
9.1.1 Medtronic Biologics in Spine Surgery Basic Information
9.1.2 Medtronic Biologics in Spine Surgery Product Overview
9.1.3 Medtronic Biologics in Spine Surgery Product Market Performance
9.1.4 Medtronic Business Overview
9.1.5 Medtronic Biologics in Spine Surgery SWOT Analysis
9.1.6 Medtronic Recent Developments
9.2 J and J
9.2.1 J and J Biologics in Spine Surgery Basic Information
9.2.2 J and J Biologics in Spine Surgery Product Overview
9.2.3 J and J Biologics in Spine Surgery Product Market Performance
9.2.4 J and J Business Overview
9.2.5 J and J Biologics in Spine Surgery SWOT Analysis
9.2.6 J and J Recent Developments
9.3 Stryker Corporation
9.3.1 Stryker Corporation Biologics in Spine Surgery Basic Information
9.3.2 Stryker Corporation Biologics in Spine Surgery Product Overview
9.3.3 Stryker Corporation Biologics in Spine Surgery Product Market Performance
9.3.4 Stryker Corporation Biologics in Spine Surgery SWOT Analysis
9.3.5 Stryker Corporation Business Overview
9.3.6 Stryker Corporation Recent Developments
9.4 Nuvasive
9.4.1 Nuvasive Biologics in Spine Surgery Basic Information
9.4.2 Nuvasive Biologics in Spine Surgery Product Overview
9.4.3 Nuvasive Biologics in Spine Surgery Product Market Performance
9.4.4 Nuvasive Business Overview
9.4.5 Nuvasive Recent Developments
9.5 Zimmer Biomet
9.5.1 Zimmer Biomet Biologics in Spine Surgery Basic Information
9.5.2 Zimmer Biomet Biologics in Spine Surgery Product Overview
9.5.3 Zimmer Biomet Biologics in Spine Surgery Product Market Performance
9.5.4 Zimmer Biomet Business Overview
9.5.5 Zimmer Biomet Recent Developments
9.6 Orthofix International
9.6.1 Orthofix International Biologics in Spine Surgery Basic Information
9.6.2 Orthofix International Biologics in Spine Surgery Product Overview
9.6.3 Orthofix International Biologics in Spine Surgery Product Market Performance
9.6.4 Orthofix International Business Overview
9.6.5 Orthofix International Recent Developments
9.7 Globus Medical
9.7.1 Globus Medical Biologics in Spine Surgery Basic Information
9.7.2 Globus Medical Biologics in Spine Surgery Product Overview
9.7.3 Globus Medical Biologics in Spine Surgery Product Market Performance
9.7.4 Globus Medical Business Overview
9.7.5 Globus Medical Recent Developments
9.8 alphatec spine
9.8.1 alphatec spine Biologics in Spine Surgery Basic Information
9.8.2 alphatec spine Biologics in Spine Surgery Product Overview
9.8.3 alphatec spine Biologics in Spine Surgery Product Market Performance
9.8.4 alphatec spine Business Overview
9.8.5 alphatec spine Recent Developments
9.9 K2M
9.9.1 K2M Biologics in Spine Surgery Basic Information
9.9.2 K2M Biologics in Spine Surgery Product Overview
9.9.3 K2M Biologics in Spine Surgery Product Market Performance
9.9.4 K2M Business Overview
9.9.5 K2M Recent Developments
9.10 Exactech
9.10.1 Exactech Biologics in Spine Surgery Basic Information
9.10.2 Exactech Biologics in Spine Surgery Product Overview
9.10.3 Exactech Biologics in Spine Surgery Product Market Performance
9.10.4 Exactech Business Overview
9.10.5 Exactech Recent Developments
9.11 Wright Medical Technology
9.11.1 Wright Medical Technology Biologics in Spine Surgery Basic Information
9.11.2 Wright Medical Technology Biologics in Spine Surgery Product Overview
9.11.3 Wright Medical Technology Biologics in Spine Surgery Product Market Performance
9.11.4 Wright Medical Technology Business Overview
9.11.5 Wright Medical Technology Recent Developments
9.12 X-Spine
9.12.1 X-Spine Biologics in Spine Surgery Basic Information
9.12.2 X-Spine Biologics in Spine Surgery Product Overview
9.12.3 X-Spine Biologics in Spine Surgery Product Market Performance
9.12.4 X-Spine Business Overview
9.12.5 X-Spine Recent Developments
9.13 Nutech
9.13.1 Nutech Biologics in Spine Surgery Basic Information
9.13.2 Nutech Biologics in Spine Surgery Product Overview
9.13.3 Nutech Biologics in Spine Surgery Product Market Performance
9.13.4 Nutech Business Overview
9.13.5 Nutech Recent Developments
9.14 Arthrex
9.14.1 Arthrex Biologics in Spine Surgery Basic Information
9.14.2 Arthrex Biologics in Spine Surgery Product Overview
9.14.3 Arthrex Biologics in Spine Surgery Product Market Performance
9.14.4 Arthrex Business Overview
9.14.5 Arthrex Recent Developments
10 BIOLOGICS IN SPINE SURGERY MARKET FORECAST BY REGION
10.1 Global Biologics in Spine Surgery Market Size Forecast
10.2 Global Biologics in Spine Surgery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologics in Spine Surgery Market Size Forecast by Country
10.2.3 Asia Pacific Biologics in Spine Surgery Market Size Forecast by Region
10.2.4 South America Biologics in Spine Surgery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologics in Spine Surgery by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biologics in Spine Surgery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biologics in Spine Surgery by Type (2025-2030)
11.1.2 Global Biologics in Spine Surgery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biologics in Spine Surgery by Type (2025-2030)
11.2 Global Biologics in Spine Surgery Market Forecast by Application (2025-2030)
11.2.1 Global Biologics in Spine Surgery Sales (K Units) Forecast by Application
11.2.2 Global Biologics in Spine Surgery Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biologics in Spine Surgery
1.2 Key Market Segments
1.2.1 Biologics in Spine Surgery Segment by Type
1.2.2 Biologics in Spine Surgery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICS IN SPINE SURGERY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biologics in Spine Surgery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biologics in Spine Surgery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICS IN SPINE SURGERY MARKET COMPETITIVE LANDSCAPE
3.1 Global Biologics in Spine Surgery Sales by Manufacturers (2019-2024)
3.2 Global Biologics in Spine Surgery Revenue Market Share by Manufacturers (2019-2024)
3.3 Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics in Spine Surgery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biologics in Spine Surgery Sales Sites, Area Served, Product Type
3.6 Biologics in Spine Surgery Market Competitive Situation and Trends
3.6.1 Biologics in Spine Surgery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics in Spine Surgery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGICS IN SPINE SURGERY INDUSTRY CHAIN ANALYSIS
4.1 Biologics in Spine Surgery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICS IN SPINE SURGERY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOLOGICS IN SPINE SURGERY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics in Spine Surgery Sales Market Share by Type (2019-2024)
6.3 Global Biologics in Spine Surgery Market Size Market Share by Type (2019-2024)
6.4 Global Biologics in Spine Surgery Price by Type (2019-2024)
7 BIOLOGICS IN SPINE SURGERY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics in Spine Surgery Market Sales by Application (2019-2024)
7.3 Global Biologics in Spine Surgery Market Size (M USD) by Application (2019-2024)
7.4 Global Biologics in Spine Surgery Sales Growth Rate by Application (2019-2024)
8 BIOLOGICS IN SPINE SURGERY MARKET SEGMENTATION BY REGION
8.1 Global Biologics in Spine Surgery Sales by Region
8.1.1 Global Biologics in Spine Surgery Sales by Region
8.1.2 Global Biologics in Spine Surgery Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics in Spine Surgery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics in Spine Surgery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics in Spine Surgery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics in Spine Surgery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics in Spine Surgery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Medtronic
9.1.1 Medtronic Biologics in Spine Surgery Basic Information
9.1.2 Medtronic Biologics in Spine Surgery Product Overview
9.1.3 Medtronic Biologics in Spine Surgery Product Market Performance
9.1.4 Medtronic Business Overview
9.1.5 Medtronic Biologics in Spine Surgery SWOT Analysis
9.1.6 Medtronic Recent Developments
9.2 J and J
9.2.1 J and J Biologics in Spine Surgery Basic Information
9.2.2 J and J Biologics in Spine Surgery Product Overview
9.2.3 J and J Biologics in Spine Surgery Product Market Performance
9.2.4 J and J Business Overview
9.2.5 J and J Biologics in Spine Surgery SWOT Analysis
9.2.6 J and J Recent Developments
9.3 Stryker Corporation
9.3.1 Stryker Corporation Biologics in Spine Surgery Basic Information
9.3.2 Stryker Corporation Biologics in Spine Surgery Product Overview
9.3.3 Stryker Corporation Biologics in Spine Surgery Product Market Performance
9.3.4 Stryker Corporation Biologics in Spine Surgery SWOT Analysis
9.3.5 Stryker Corporation Business Overview
9.3.6 Stryker Corporation Recent Developments
9.4 Nuvasive
9.4.1 Nuvasive Biologics in Spine Surgery Basic Information
9.4.2 Nuvasive Biologics in Spine Surgery Product Overview
9.4.3 Nuvasive Biologics in Spine Surgery Product Market Performance
9.4.4 Nuvasive Business Overview
9.4.5 Nuvasive Recent Developments
9.5 Zimmer Biomet
9.5.1 Zimmer Biomet Biologics in Spine Surgery Basic Information
9.5.2 Zimmer Biomet Biologics in Spine Surgery Product Overview
9.5.3 Zimmer Biomet Biologics in Spine Surgery Product Market Performance
9.5.4 Zimmer Biomet Business Overview
9.5.5 Zimmer Biomet Recent Developments
9.6 Orthofix International
9.6.1 Orthofix International Biologics in Spine Surgery Basic Information
9.6.2 Orthofix International Biologics in Spine Surgery Product Overview
9.6.3 Orthofix International Biologics in Spine Surgery Product Market Performance
9.6.4 Orthofix International Business Overview
9.6.5 Orthofix International Recent Developments
9.7 Globus Medical
9.7.1 Globus Medical Biologics in Spine Surgery Basic Information
9.7.2 Globus Medical Biologics in Spine Surgery Product Overview
9.7.3 Globus Medical Biologics in Spine Surgery Product Market Performance
9.7.4 Globus Medical Business Overview
9.7.5 Globus Medical Recent Developments
9.8 alphatec spine
9.8.1 alphatec spine Biologics in Spine Surgery Basic Information
9.8.2 alphatec spine Biologics in Spine Surgery Product Overview
9.8.3 alphatec spine Biologics in Spine Surgery Product Market Performance
9.8.4 alphatec spine Business Overview
9.8.5 alphatec spine Recent Developments
9.9 K2M
9.9.1 K2M Biologics in Spine Surgery Basic Information
9.9.2 K2M Biologics in Spine Surgery Product Overview
9.9.3 K2M Biologics in Spine Surgery Product Market Performance
9.9.4 K2M Business Overview
9.9.5 K2M Recent Developments
9.10 Exactech
9.10.1 Exactech Biologics in Spine Surgery Basic Information
9.10.2 Exactech Biologics in Spine Surgery Product Overview
9.10.3 Exactech Biologics in Spine Surgery Product Market Performance
9.10.4 Exactech Business Overview
9.10.5 Exactech Recent Developments
9.11 Wright Medical Technology
9.11.1 Wright Medical Technology Biologics in Spine Surgery Basic Information
9.11.2 Wright Medical Technology Biologics in Spine Surgery Product Overview
9.11.3 Wright Medical Technology Biologics in Spine Surgery Product Market Performance
9.11.4 Wright Medical Technology Business Overview
9.11.5 Wright Medical Technology Recent Developments
9.12 X-Spine
9.12.1 X-Spine Biologics in Spine Surgery Basic Information
9.12.2 X-Spine Biologics in Spine Surgery Product Overview
9.12.3 X-Spine Biologics in Spine Surgery Product Market Performance
9.12.4 X-Spine Business Overview
9.12.5 X-Spine Recent Developments
9.13 Nutech
9.13.1 Nutech Biologics in Spine Surgery Basic Information
9.13.2 Nutech Biologics in Spine Surgery Product Overview
9.13.3 Nutech Biologics in Spine Surgery Product Market Performance
9.13.4 Nutech Business Overview
9.13.5 Nutech Recent Developments
9.14 Arthrex
9.14.1 Arthrex Biologics in Spine Surgery Basic Information
9.14.2 Arthrex Biologics in Spine Surgery Product Overview
9.14.3 Arthrex Biologics in Spine Surgery Product Market Performance
9.14.4 Arthrex Business Overview
9.14.5 Arthrex Recent Developments
10 BIOLOGICS IN SPINE SURGERY MARKET FORECAST BY REGION
10.1 Global Biologics in Spine Surgery Market Size Forecast
10.2 Global Biologics in Spine Surgery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologics in Spine Surgery Market Size Forecast by Country
10.2.3 Asia Pacific Biologics in Spine Surgery Market Size Forecast by Region
10.2.4 South America Biologics in Spine Surgery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologics in Spine Surgery by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biologics in Spine Surgery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biologics in Spine Surgery by Type (2025-2030)
11.1.2 Global Biologics in Spine Surgery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biologics in Spine Surgery by Type (2025-2030)
11.2 Global Biologics in Spine Surgery Market Forecast by Application (2025-2030)
11.2.1 Global Biologics in Spine Surgery Sales (K Units) Forecast by Application
11.2.2 Global Biologics in Spine Surgery Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics in Spine Surgery Market Size Comparison by Region (M USD)
Table 5. Global Biologics in Spine Surgery Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biologics in Spine Surgery Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biologics in Spine Surgery Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics in Spine Surgery as of 2022)
Table 10. Global Market Biologics in Spine Surgery Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biologics in Spine Surgery Sales Sites and Area Served
Table 12. Manufacturers Biologics in Spine Surgery Product Type
Table 13. Global Biologics in Spine Surgery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologics in Spine Surgery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologics in Spine Surgery Market Challenges
Table 22. Global Biologics in Spine Surgery Sales by Type (K Units)
Table 23. Global Biologics in Spine Surgery Market Size by Type (M USD)
Table 24. Global Biologics in Spine Surgery Sales (K Units) by Type (2019-2024)
Table 25. Global Biologics in Spine Surgery Sales Market Share by Type (2019-2024)
Table 26. Global Biologics in Spine Surgery Market Size (M USD) by Type (2019-2024)
Table 27. Global Biologics in Spine Surgery Market Size Share by Type (2019-2024)
Table 28. Global Biologics in Spine Surgery Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biologics in Spine Surgery Sales (K Units) by Application
Table 30. Global Biologics in Spine Surgery Market Size by Application
Table 31. Global Biologics in Spine Surgery Sales by Application (2019-2024) & (K Units)
Table 32. Global Biologics in Spine Surgery Sales Market Share by Application (2019-2024)
Table 33. Global Biologics in Spine Surgery Sales by Application (2019-2024) & (M USD)
Table 34. Global Biologics in Spine Surgery Market Share by Application (2019-2024)
Table 35. Global Biologics in Spine Surgery Sales Growth Rate by Application (2019-2024)
Table 36. Global Biologics in Spine Surgery Sales by Region (2019-2024) & (K Units)
Table 37. Global Biologics in Spine Surgery Sales Market Share by Region (2019-2024)
Table 38. North America Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biologics in Spine Surgery Sales by Region (2019-2024) & (K Units)
Table 41. South America Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biologics in Spine Surgery Sales by Region (2019-2024) & (K Units)
Table 43. Medtronic Biologics in Spine Surgery Basic Information
Table 44. Medtronic Biologics in Spine Surgery Product Overview
Table 45. Medtronic Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Medtronic Business Overview
Table 47. Medtronic Biologics in Spine Surgery SWOT Analysis
Table 48. Medtronic Recent Developments
Table 49. J and J Biologics in Spine Surgery Basic Information
Table 50. J and J Biologics in Spine Surgery Product Overview
Table 51. J and J Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. J and J Business Overview
Table 53. J and J Biologics in Spine Surgery SWOT Analysis
Table 54. J and J Recent Developments
Table 55. Stryker Corporation Biologics in Spine Surgery Basic Information
Table 56. Stryker Corporation Biologics in Spine Surgery Product Overview
Table 57. Stryker Corporation Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Stryker Corporation Biologics in Spine Surgery SWOT Analysis
Table 59. Stryker Corporation Business Overview
Table 60. Stryker Corporation Recent Developments
Table 61. Nuvasive Biologics in Spine Surgery Basic Information
Table 62. Nuvasive Biologics in Spine Surgery Product Overview
Table 63. Nuvasive Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Nuvasive Business Overview
Table 65. Nuvasive Recent Developments
Table 66. Zimmer Biomet Biologics in Spine Surgery Basic Information
Table 67. Zimmer Biomet Biologics in Spine Surgery Product Overview
Table 68. Zimmer Biomet Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Zimmer Biomet Business Overview
Table 70. Zimmer Biomet Recent Developments
Table 71. Orthofix International Biologics in Spine Surgery Basic Information
Table 72. Orthofix International Biologics in Spine Surgery Product Overview
Table 73. Orthofix International Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Orthofix International Business Overview
Table 75. Orthofix International Recent Developments
Table 76. Globus Medical Biologics in Spine Surgery Basic Information
Table 77. Globus Medical Biologics in Spine Surgery Product Overview
Table 78. Globus Medical Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Globus Medical Business Overview
Table 80. Globus Medical Recent Developments
Table 81. alphatec spine Biologics in Spine Surgery Basic Information
Table 82. alphatec spine Biologics in Spine Surgery Product Overview
Table 83. alphatec spine Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. alphatec spine Business Overview
Table 85. alphatec spine Recent Developments
Table 86. K2M Biologics in Spine Surgery Basic Information
Table 87. K2M Biologics in Spine Surgery Product Overview
Table 88. K2M Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. K2M Business Overview
Table 90. K2M Recent Developments
Table 91. Exactech Biologics in Spine Surgery Basic Information
Table 92. Exactech Biologics in Spine Surgery Product Overview
Table 93. Exactech Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Exactech Business Overview
Table 95. Exactech Recent Developments
Table 96. Wright Medical Technology Biologics in Spine Surgery Basic Information
Table 97. Wright Medical Technology Biologics in Spine Surgery Product Overview
Table 98. Wright Medical Technology Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Wright Medical Technology Business Overview
Table 100. Wright Medical Technology Recent Developments
Table 101. X-Spine Biologics in Spine Surgery Basic Information
Table 102. X-Spine Biologics in Spine Surgery Product Overview
Table 103. X-Spine Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. X-Spine Business Overview
Table 105. X-Spine Recent Developments
Table 106. Nutech Biologics in Spine Surgery Basic Information
Table 107. Nutech Biologics in Spine Surgery Product Overview
Table 108. Nutech Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Nutech Business Overview
Table 110. Nutech Recent Developments
Table 111. Arthrex Biologics in Spine Surgery Basic Information
Table 112. Arthrex Biologics in Spine Surgery Product Overview
Table 113. Arthrex Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Arthrex Business Overview
Table 115. Arthrex Recent Developments
Table 116. Global Biologics in Spine Surgery Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Biologics in Spine Surgery Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Biologics in Spine Surgery Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Biologics in Spine Surgery Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Biologics in Spine Surgery Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Biologics in Spine Surgery Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Biologics in Spine Surgery Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Biologics in Spine Surgery Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Biologics in Spine Surgery Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Biologics in Spine Surgery Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Biologics in Spine Surgery Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Biologics in Spine Surgery Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Biologics in Spine Surgery Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Biologics in Spine Surgery Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Biologics in Spine Surgery Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Biologics in Spine Surgery Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Biologics in Spine Surgery Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics in Spine Surgery Market Size Comparison by Region (M USD)
Table 5. Global Biologics in Spine Surgery Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biologics in Spine Surgery Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biologics in Spine Surgery Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics in Spine Surgery as of 2022)
Table 10. Global Market Biologics in Spine Surgery Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biologics in Spine Surgery Sales Sites and Area Served
Table 12. Manufacturers Biologics in Spine Surgery Product Type
Table 13. Global Biologics in Spine Surgery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologics in Spine Surgery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologics in Spine Surgery Market Challenges
Table 22. Global Biologics in Spine Surgery Sales by Type (K Units)
Table 23. Global Biologics in Spine Surgery Market Size by Type (M USD)
Table 24. Global Biologics in Spine Surgery Sales (K Units) by Type (2019-2024)
Table 25. Global Biologics in Spine Surgery Sales Market Share by Type (2019-2024)
Table 26. Global Biologics in Spine Surgery Market Size (M USD) by Type (2019-2024)
Table 27. Global Biologics in Spine Surgery Market Size Share by Type (2019-2024)
Table 28. Global Biologics in Spine Surgery Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biologics in Spine Surgery Sales (K Units) by Application
Table 30. Global Biologics in Spine Surgery Market Size by Application
Table 31. Global Biologics in Spine Surgery Sales by Application (2019-2024) & (K Units)
Table 32. Global Biologics in Spine Surgery Sales Market Share by Application (2019-2024)
Table 33. Global Biologics in Spine Surgery Sales by Application (2019-2024) & (M USD)
Table 34. Global Biologics in Spine Surgery Market Share by Application (2019-2024)
Table 35. Global Biologics in Spine Surgery Sales Growth Rate by Application (2019-2024)
Table 36. Global Biologics in Spine Surgery Sales by Region (2019-2024) & (K Units)
Table 37. Global Biologics in Spine Surgery Sales Market Share by Region (2019-2024)
Table 38. North America Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biologics in Spine Surgery Sales by Region (2019-2024) & (K Units)
Table 41. South America Biologics in Spine Surgery Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biologics in Spine Surgery Sales by Region (2019-2024) & (K Units)
Table 43. Medtronic Biologics in Spine Surgery Basic Information
Table 44. Medtronic Biologics in Spine Surgery Product Overview
Table 45. Medtronic Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Medtronic Business Overview
Table 47. Medtronic Biologics in Spine Surgery SWOT Analysis
Table 48. Medtronic Recent Developments
Table 49. J and J Biologics in Spine Surgery Basic Information
Table 50. J and J Biologics in Spine Surgery Product Overview
Table 51. J and J Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. J and J Business Overview
Table 53. J and J Biologics in Spine Surgery SWOT Analysis
Table 54. J and J Recent Developments
Table 55. Stryker Corporation Biologics in Spine Surgery Basic Information
Table 56. Stryker Corporation Biologics in Spine Surgery Product Overview
Table 57. Stryker Corporation Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Stryker Corporation Biologics in Spine Surgery SWOT Analysis
Table 59. Stryker Corporation Business Overview
Table 60. Stryker Corporation Recent Developments
Table 61. Nuvasive Biologics in Spine Surgery Basic Information
Table 62. Nuvasive Biologics in Spine Surgery Product Overview
Table 63. Nuvasive Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Nuvasive Business Overview
Table 65. Nuvasive Recent Developments
Table 66. Zimmer Biomet Biologics in Spine Surgery Basic Information
Table 67. Zimmer Biomet Biologics in Spine Surgery Product Overview
Table 68. Zimmer Biomet Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Zimmer Biomet Business Overview
Table 70. Zimmer Biomet Recent Developments
Table 71. Orthofix International Biologics in Spine Surgery Basic Information
Table 72. Orthofix International Biologics in Spine Surgery Product Overview
Table 73. Orthofix International Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Orthofix International Business Overview
Table 75. Orthofix International Recent Developments
Table 76. Globus Medical Biologics in Spine Surgery Basic Information
Table 77. Globus Medical Biologics in Spine Surgery Product Overview
Table 78. Globus Medical Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Globus Medical Business Overview
Table 80. Globus Medical Recent Developments
Table 81. alphatec spine Biologics in Spine Surgery Basic Information
Table 82. alphatec spine Biologics in Spine Surgery Product Overview
Table 83. alphatec spine Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. alphatec spine Business Overview
Table 85. alphatec spine Recent Developments
Table 86. K2M Biologics in Spine Surgery Basic Information
Table 87. K2M Biologics in Spine Surgery Product Overview
Table 88. K2M Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. K2M Business Overview
Table 90. K2M Recent Developments
Table 91. Exactech Biologics in Spine Surgery Basic Information
Table 92. Exactech Biologics in Spine Surgery Product Overview
Table 93. Exactech Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Exactech Business Overview
Table 95. Exactech Recent Developments
Table 96. Wright Medical Technology Biologics in Spine Surgery Basic Information
Table 97. Wright Medical Technology Biologics in Spine Surgery Product Overview
Table 98. Wright Medical Technology Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Wright Medical Technology Business Overview
Table 100. Wright Medical Technology Recent Developments
Table 101. X-Spine Biologics in Spine Surgery Basic Information
Table 102. X-Spine Biologics in Spine Surgery Product Overview
Table 103. X-Spine Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. X-Spine Business Overview
Table 105. X-Spine Recent Developments
Table 106. Nutech Biologics in Spine Surgery Basic Information
Table 107. Nutech Biologics in Spine Surgery Product Overview
Table 108. Nutech Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Nutech Business Overview
Table 110. Nutech Recent Developments
Table 111. Arthrex Biologics in Spine Surgery Basic Information
Table 112. Arthrex Biologics in Spine Surgery Product Overview
Table 113. Arthrex Biologics in Spine Surgery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Arthrex Business Overview
Table 115. Arthrex Recent Developments
Table 116. Global Biologics in Spine Surgery Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Biologics in Spine Surgery Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Biologics in Spine Surgery Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Biologics in Spine Surgery Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Biologics in Spine Surgery Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Biologics in Spine Surgery Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Biologics in Spine Surgery Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Biologics in Spine Surgery Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Biologics in Spine Surgery Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Biologics in Spine Surgery Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Biologics in Spine Surgery Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Biologics in Spine Surgery Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Biologics in Spine Surgery Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Biologics in Spine Surgery Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Biologics in Spine Surgery Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Biologics in Spine Surgery Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Biologics in Spine Surgery Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biologics in Spine Surgery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics in Spine Surgery Market Size (M USD), 2019-2030
Figure 5. Global Biologics in Spine Surgery Market Size (M USD) (2019-2030)
Figure 6. Global Biologics in Spine Surgery Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics in Spine Surgery Market Size by Country (M USD)
Figure 11. Biologics in Spine Surgery Sales Share by Manufacturers in 2023
Figure 12. Global Biologics in Spine Surgery Revenue Share by Manufacturers in 2023
Figure 13. Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologics in Spine Surgery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologics in Spine Surgery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologics in Spine Surgery Market Share by Type
Figure 18. Sales Market Share of Biologics in Spine Surgery by Type (2019-2024)
Figure 19. Sales Market Share of Biologics in Spine Surgery by Type in 2023
Figure 20. Market Size Share of Biologics in Spine Surgery by Type (2019-2024)
Figure 21. Market Size Market Share of Biologics in Spine Surgery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologics in Spine Surgery Market Share by Application
Figure 24. Global Biologics in Spine Surgery Sales Market Share by Application (2019-2024)
Figure 25. Global Biologics in Spine Surgery Sales Market Share by Application in 2023
Figure 26. Global Biologics in Spine Surgery Market Share by Application (2019-2024)
Figure 27. Global Biologics in Spine Surgery Market Share by Application in 2023
Figure 28. Global Biologics in Spine Surgery Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biologics in Spine Surgery Sales Market Share by Region (2019-2024)
Figure 30. North America Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biologics in Spine Surgery Sales Market Share by Country in 2023
Figure 32. U.S. Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biologics in Spine Surgery Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biologics in Spine Surgery Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biologics in Spine Surgery Sales Market Share by Country in 2023
Figure 37. Germany Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biologics in Spine Surgery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biologics in Spine Surgery Sales Market Share by Region in 2023
Figure 44. China Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biologics in Spine Surgery Sales and Growth Rate (K Units)
Figure 50. South America Biologics in Spine Surgery Sales Market Share by Country in 2023
Figure 51. Brazil Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biologics in Spine Surgery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biologics in Spine Surgery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biologics in Spine Surgery Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biologics in Spine Surgery Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biologics in Spine Surgery Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biologics in Spine Surgery Market Share Forecast by Type (2025-2030)
Figure 65. Global Biologics in Spine Surgery Sales Forecast by Application (2025-2030)
Figure 66. Global Biologics in Spine Surgery Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Biologics in Spine Surgery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics in Spine Surgery Market Size (M USD), 2019-2030
Figure 5. Global Biologics in Spine Surgery Market Size (M USD) (2019-2030)
Figure 6. Global Biologics in Spine Surgery Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics in Spine Surgery Market Size by Country (M USD)
Figure 11. Biologics in Spine Surgery Sales Share by Manufacturers in 2023
Figure 12. Global Biologics in Spine Surgery Revenue Share by Manufacturers in 2023
Figure 13. Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologics in Spine Surgery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologics in Spine Surgery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologics in Spine Surgery Market Share by Type
Figure 18. Sales Market Share of Biologics in Spine Surgery by Type (2019-2024)
Figure 19. Sales Market Share of Biologics in Spine Surgery by Type in 2023
Figure 20. Market Size Share of Biologics in Spine Surgery by Type (2019-2024)
Figure 21. Market Size Market Share of Biologics in Spine Surgery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologics in Spine Surgery Market Share by Application
Figure 24. Global Biologics in Spine Surgery Sales Market Share by Application (2019-2024)
Figure 25. Global Biologics in Spine Surgery Sales Market Share by Application in 2023
Figure 26. Global Biologics in Spine Surgery Market Share by Application (2019-2024)
Figure 27. Global Biologics in Spine Surgery Market Share by Application in 2023
Figure 28. Global Biologics in Spine Surgery Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biologics in Spine Surgery Sales Market Share by Region (2019-2024)
Figure 30. North America Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biologics in Spine Surgery Sales Market Share by Country in 2023
Figure 32. U.S. Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biologics in Spine Surgery Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biologics in Spine Surgery Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biologics in Spine Surgery Sales Market Share by Country in 2023
Figure 37. Germany Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biologics in Spine Surgery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biologics in Spine Surgery Sales Market Share by Region in 2023
Figure 44. China Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biologics in Spine Surgery Sales and Growth Rate (K Units)
Figure 50. South America Biologics in Spine Surgery Sales Market Share by Country in 2023
Figure 51. Brazil Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biologics in Spine Surgery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biologics in Spine Surgery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biologics in Spine Surgery Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biologics in Spine Surgery Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biologics in Spine Surgery Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biologics in Spine Surgery Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biologics in Spine Surgery Market Share Forecast by Type (2025-2030)
Figure 65. Global Biologics in Spine Surgery Sales Forecast by Application (2025-2030)
Figure 66. Global Biologics in Spine Surgery Market Share Forecast by Application (2025-2030)
